GENEVA, June 19 -- JANSSEN PHARMACEUTICA NV filed a patent application (US2025/055385) for “METHODS OF TREATING DEPRESSION USING A MUSCARINIC ACETYLCHOLINE RECEPTOR M1 ANTAGONIST”. With publication no. WO/2026/107228, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/496
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....